What we now want is the last sentence ín situ for humans. I'm not sure of the time line for this trial but I know of other trials where scans are taken at 2 months to track the effectiveness, and safety is monitored along the way.
Ann: First patient dosed in Phase 1/2 trial of CHM CDH17, page-3
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable